|Notification date||01 January 2012|
NICE is developing guidance on this technology. If you would like to become a registered stakeholder in the development of guidance on this technology, please complete a stakeholder registration and confidentiality form (Word), and return to us at email@example.com.
Registered stakeholders will be informed of key stages in the development of guidance including when documents go out to consultation or comment.
|26 May 2016||Discontinued. NICE was unable to develop medical technologies guidance on Clinitek Microalbumin 9 reagent strips for the early detection and monitoring of kidney disease because no evidence submission was received from the company.|
|6 December 2012||The National Institute for Health and Clinical Excellence (NICE) is evaluating this technology. For further details on the process please see the Process and Methods Guides.|
For further information on how we develop guidance, please see our page about NICE medical technologies guidance